Developing a new leprosy diagnostic test
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2007Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PAI LIFE SCIENCES INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MSMLUCM9DRT6
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Antigen and adjuvant selection for a vaccine against urogenital schistosomiasis, Hematoshield
- A Vaccine for Lymphatic Filariasis, LFGuard™
- Evaluation of a Next Generation SchistoShield Vaccine
- LATE STAGE ADJUVANT MIMICS BASED ON TLR4 AGONISTS
- Adjuvanted Recombinant Candidates to Prime / Boost COVID-19 RNA Vaccines
Research funding history
28 SBIR/STTR records share this UEI (2007–2024). Reported award amounts total $23,806,620. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services